From: Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
Parameter
T/R (%)
90% CIs
Power (%)
Cmax
96.48
90.93–102.37%
99.98
AUC0–t
100.24
95.75–104.93%
100.00
AUC0–∞
100.22
95.36–105.33%